Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Rotavirus
Adults
Older adults
Clear all
Type of publications
Systematic reviews (SYSVAC)
(13)
Topics
Available to download in languages
Regions
Americas
(2)
Europe
(2)
Western Pacific
(2)
Countries
Diseases
COVID-19
(1)
Influenza
(11)
Rotavirus
(1)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(6)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(21)
Measles
(2)
Meningococcal disease
(1)
Mumps
(2)
Pertussis
(1)
Pneumococcal disease
(5)
Rubella
(2)
Tetanus
(1)
Varicella
(2)
Vaccine topics
Economic aspects
(13)
Acceptance
(45)
Administration
(78)
Coverage
(19)
Efficacy/effectiveness
(218)
Ethical issues
(7)
Safety
(259)
Target population
Adults
(7)
Older adults
(9)
Adolescents
(3)
All age groups
(36)
Children
(7)
Healthcare workers
(8)
Newborn
(6)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2023
(1)
2022
(2)
2021
(3)
2019
(3)
2018
(1)
2017
(2)
2012
(1)
13 results found
2023
∙
Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
2022
∙
Dilokthornsakul, P. Lan, L. M. Thakkinstian, A. Hutubessy, R. Lambach, P. Chaiyakunapruk, N.
Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2021
∙
Colrat, F. Thommes, E. Largeron, N. Alvarez, F. P.
Economic evaluation of high-dose inactivated influenza vaccine in adults aged >=65 years: A systematic literature review
2021
∙
Ofori, S. K. Hung, Y. W. Schwind, J. S. Diallo, K. Babatunde, D. Nwaobi, S. O. Hua, X. Sullivan, K. L. Cowling, B. J. Chowell, G. Fung, I. C. H.
Economic evaluations of interventions against influenza at workplaces: systematic review
2021
∙
Taniguchi, K. Ikeda, S. Hagiwara, Y. Tsuzuki, D. Klai, M. Sakai, Y. Crawford, B. Nealon, J.
Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta-analysis
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
2019
∙
Loperto, I. Simonetti, A. Nardone, A. Triassi, M.
Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
2019
∙
Madeddu, G. Vroling, H. Oordt-Speets, A. Babudieri, S. O'Moore, E. Noordegraaf, M. V. Monarca, R. Lopalco, P. L. Hedrich, D. Tavoschi, L.
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
2018
∙
Kopsaftis, Z. Wood-Baker, R. Poole, P.
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register